Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure (Q44000013)

28 November 2017

Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure (English)

1 reference

28 November 2017

0 references

2

Torbjørn Omland

1 reference

28 November 2017

8

Jean-Lucien Rouleau

1 reference

28 November 2017

Wendy Johnson

1

1 reference

28 November 2017

Christian Hall

3

1 reference

28 November 2017

Caroline Lucas

4

1 reference

28 November 2017

Ole L Myking

5

1 reference

28 November 2017

Caroline Collins

6

1 reference

28 November 2017

Marc Pfeffer

7

1 reference

28 November 2017

Lynne W Stevenson

9

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

Journal of the American College of Cardiology

28 November 2017

1 reference

28 November 2017

39

1 reference

28 November 2017

10

1 reference

28 November 2017

1623-1629

1 reference

Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators.

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Effect of long-term enalapril therapy on neurohormones in patients with left ventricular dysfunction. SOLVD Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy : the randomized evaluation of strategies for left ventricular dysfunction pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Effect of the Implantable Left Ventricular Assist Device on Neuroendocrine Activation in Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: the Hy-C trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Plasma norepinephrine in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Isolated ultrafiltration in moderate congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Plasma endothelin in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Inducible endothelin mRNA expression and peptide secretion in cultured human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Down-regulation of ET(B) receptor, but not ET(A) receptor, in congestive lung secondary to heart failure. Are marked increases in circulating endothelin-1 partly attributable to decreases in lung ET(B) receptor-mediated clearance of endothelin-1?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Endothelins. Myocardial actions of a new class of cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Integrated cardiac, renal, and endocrine actions of endothelin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Endothelin stimulates release of atrial natriuretic peptides in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Pulmonary release and coronary and peripheral consumption of big endothelin and endothelin-1 in severe heart failure: acute effects of vasodilator therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Atrial natriuretic peptide elevation in congestive heart failure in the human

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Responsiveness of atrial natriuretic factor to reduction in right atrial pressure in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Effect of atrial natriuretic peptide (8-33-Met ANP) in patients with hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Attenuated forearm vasodilative response to intra-arterial atrial natriuretic peptide in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Uncoupling of atrial natriuretic peptide extraction and cyclic guanosine monophosphate production in the pulmonary circulation in patients with severe heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Possibility of downregulation of atrial natriuretic peptide receptor coupled to guanylate cyclase in peripheral vascular beds of patients with chronic severe heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901814-4

7 January 2021

10.1016/S0735-1097(02)01814-4

Identifiers

DOI

1 reference

28 November 2017

1 reference